Home
About
Pricing
Log In
Back
MEMN

This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.

Asset Logo

Memphasys Limited

πŸ‡¦πŸ‡Ί ASX

πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸƒ Esg

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

N/A
Annual Growth

5 years average annual capital growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

3
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Memphasys Limited - Ordinary Fully Paid Deferred

πŸ“ˆ Performance

Price History

N/A

1M

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in MEMN

3

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

N/A

πŸ’΅ Average investment amount

N/A

⏰ Last time a customer invested in MEMN

N/A
MEMN investor breakdown
πŸ’΅ Income of investors

More than 200k

25%

150k - 200k

100k - 150k

25%

50k - 100k

Less than 50k

50%
πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

100%
πŸ™‹ Legal gender of investors

Female

33%

Male

67%

Pearlers who invest in MEMN also invest in...

Memphasys Limited

MEM

Memphasys Ltd. is a life sciences company, which engages in the development and commercialization of novel reproduction and fertility solutions for humans and animals. The company is headquartered in Homebush West, New South Wales. The company went IPO on 2007-05-14. The firm is engaged in developing medical devices, diagnostics, and media with application to assisted reproductive technology (ART) in humans and animals. The firm's product pipeline includes Felix, RoXsta, and AI-Port. Its advanced product, the Felix System, is a patented automated device for quickly and gently separating sperm from a semen sample for use in ART procedures. The Felix device consists of two main components: a console, which supplies electrical power, and a sterile disposable cartridge for sperm isolation and selection. RoXsta is an in-vitro diagnostic device that assesses semen and other bodily fluids for oxidative stress load. RoXsta also has an application as part of a suite of products that can support the animal industry. AI-Port has been developed for the purpose of maintaining the viability of livestock semen for up to seven days at a temperature range of 22 - 25 degrees Celsius.

πŸ™Œ Performance (5Yr p.a)

-19.27%

πŸ“Š Share price

$0.00 AUD

πŸ”­ LIFE SCIENCES TOOLS & SERVICES

Find Out More

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

πŸ™Œ Performance (5Yr p.a)

22.24%

πŸ“Š Share price

$57.09 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ‡ΊπŸ‡Έ UNITED STATES

πŸ€– TECHNOLOGY

Gold

PMGOLD

PMGOLD.AX was created on 2003-05-09 by Perth Mint. The fund's investment portfolio concentrates primarily on gold commodities. PMGOLD.AX is designed to track the international price of gold in Australian dollars and offers investors a simple, low cost way to access the returns on gold.

πŸ™Œ Performance (5Yr p.a)

27.15%

πŸ“Š Share price

$62.88 AUD

πŸ“ˆ HIGH PRICE GROWTH

Amcor Plc operates as a holding company, which engages in the provision of consumer packaging business. The company is headquartered in Zurich, Zuerich and currently employs 42,000 full-time employees. The company went IPO on 2019-06-11. The firm develops sustainable packaging in flexible and rigid formats across multiple materials. The firm operates through two segments: Flexibles and Rigid Packaging. The Flexibles segment consists of operations that manufacture flexible and film packaging in the food and beverage, medical and pharmaceutical, fresh produce, snack food, personal care, and other industries. The Rigid Packaging segment consists of operations that manufacture rigid containers for a broad range of predominantly beverage and food products, including carbonated soft drinks, water, juices, sports drinks, milk-based beverages, spirits and wine, sauces, dressings, spreads and personal care items, and plastic caps for a wide variety of applications. The firm's subsidiaries include Berry Global Group Inc., Amcor Flexibles North America, Inc., Amcor UK Finance plc, Amcor Finance (USA), Inc., and others.

πŸ™Œ Performance (5Yr p.a)

-3.36%

πŸ“Š Share price

$12.62 AUD

πŸ“¦ LOGISTICS

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.

πŸ™Œ Performance (5Yr p.a)

9.13%

πŸ“Š Share price

$150.35 AUD

πŸ‡¦πŸ‡Ί AUSTRALIA

πŸ’Έ FINANCIALS

⛳️ DIVERSIFIED

πŸ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...